Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Journal of Family Planning and Reproductive Health Care 2003: 29(3) What is inflammatory bowel disease (IBD)? Inflammatory bowel disease (IBD) refers to two distinct disorders – Crohn’s disease (CD) and ulcerative colitis (UC).1 These two disorders have distinct clinical and pathological features but their cause is unknown. In patients with large bowel disease only there may be difficulty disti...

Inflammatory bowel disease (IBD) is a chronic condition involving the inflammation of the colon and small intestine. IBD affects as many as 1.4 million people in the U.S. alone and costs the health care industry over $1.7 billion annually. Managing IBD normally requires invasive and often discomforting diagnostic tests. In an effort to alleviate the painful and costly nature of traditional diag...

Inflammatory bowel disease (IBD) collectively known as Crohn's disease and ulcerative colitis are chronic inflammatory diseases of the digestive tract. Periods of active and inactive disease are common along the trajectory of this illness. A range of symptoms such as fatigue, diarrhoea and abdominal pain are experienced and are often very debilitating in nature resulting in significance interfe...

WS Historically, we have treated inflammatory bowel disease (IBD) using small molecules such as prednisone, budesonide, and mesalamine, along with immunosuppressive drugs such as azathioprine, 6-mercaptopurine, and methotrexate. Until infliximab (Remicade, Janssen) was approved in 1998, the treatment of IBD was entirely based on small molecules. Since that time, virtually all new medications ap...

Inflammatory bowel diseases (IBD) are chronic intestinal disorders caused by a number of factors, including external influences, intestinal microbiota and genetics. The two major clinically defined types of IBD are Crohn's disease and ulcerative colitis, each of which is characterized by relapses in the clinical course, thus patients must be under constant observation via regular endoscopies. A...

BACKGROUND Inflammatory bowel disease (IBD) is well recognized in developed countries and is generally among the differential diagnoses of young patients presenting with refractory diarrhea once other more common etiologies have been excluded. Pinworm infections, on the other hand, are not as common among adults in the United States. CASE REPORT Based on computed tomography features, a 24-yea...

INTRODUCTION Patients with long-standing ulcerative colitis (UC) and Crohn’s disease of the colon are at an increased risk of developing colorectal neoplasia (dysplasia and colorectal carcinoma). The association of UC with colorectal carcinoma was first recognized in the 1920s [1]. In inflammatory bowel disease (IBD) the development of colorectal carcinoma (CRC) occurs through an inflammation-d...